Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN BIOTECHNOLOGY
Volume 36, Issue 6, Pages 1110-1122
Publisher
Informa UK Limited
Online
2015-09-18
DOI
10.3109/07388551.2015.1084266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris
- (2016) Robert S. Green et al. Canadian Journal of Emergency Medicine
- Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
- (2015) Justin McCue et al. BIOLOGICALS
- Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity
- (2015) Eloïse Perot et al. THROMBOSIS RESEARCH
- MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
- (2014) Frank Behrens et al. ANNALS OF THE RHEUMATIC DISEASES
- Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality
- (2014) William C. Yang et al. BIOTECHNOLOGY PROGRESS
- The choice of mammalian cell host and possibilities for glycosylation engineering
- (2014) Michael Butler et al. CURRENT OPINION IN BIOTECHNOLOGY
- Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
- (2014) Carol Wysham et al. DIABETES CARE
- Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein
- (2014) J. McCue et al. HAEMOPHILIA
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Addition of Valproic Acid to CHO Cell Fed-Batch Cultures Improves Monoclonal Antibody Titers
- (2014) William C. Yang et al. MOLECULAR BIOTECHNOLOGY
- Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
- (2013) Yoram Tekoah et al. BIOSCIENCE REPORTS
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- (2013) J. Mahlangu et al. BLOOD
- Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers
- (2013) J.Y. Rodney et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A simple, robust and highly efficient transient expression system for producing antibodies
- (2013) Tom Vink et al. METHODS
- Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
- (2013) Jerry S. Powell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Production of Recombinant Therapeutic Proteins in Human Cells: Current Achievements and Future Perspectives
- (2013) Virgínia Picanco-Castro et al. PROTEIN AND PEPTIDE LETTERS
- Use of baculovirus expression system for generation of virus-like particles: Successes and challenges
- (2013) Fuxiao Liu et al. PROTEIN EXPRESSION AND PURIFICATION
- Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase
- (2012) Ari Zimran et al. AMERICAN JOURNAL OF HEMATOLOGY
- Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease
- (2012) Hadhami Ben Turkia et al. AMERICAN JOURNAL OF HEMATOLOGY
- Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation
- (2012) Darius Ghaderi et al. Biotechnology & Genetic Engineering Reviews
- Analysis of dynamic changes in the proteome of a Bcl-XL overexpressing Chinese hamster ovary cell culture during exponential and stationary phases
- (2012) Tyler Carlage et al. BIOTECHNOLOGY PROGRESS
- Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
- (2012) J. A. Dumont et al. BLOOD
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
- (2012) J. S. Powell et al. BLOOD
- The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
- (2012) Elisabeth Casademunt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of hypothermic temperatures on production of rabies virus glycoprotein by recombinant Drosophila melanogaster S2 cells cultured in suspension
- (2012) Nickeli Rossi et al. JOURNAL OF BIOTECHNOLOGY
- Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
- (2012) R. T. PETERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Drotrecogin Alfa (Activated) in Adults with Septic Shock
- (2012) V. Marco Ranieri et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multi-Omics Analysis of Recombinant Protein Production in Hek293 Cells
- (2012) Stefanie Dietmair et al. PLoS One
- Human cells: New platform for recombinant therapeutic protein production
- (2012) Kamilla Swiech et al. PROTEIN EXPRESSION AND PURIFICATION
- Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications
- (2012) Nathalie Enjolras et al. THROMBOSIS RESEARCH
- Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII
- (2012) Christoph Kannicht et al. THROMBOSIS RESEARCH
- CHO cells in biotechnology for production of recombinant proteins: current state and further potential
- (2011) Jee Yon Kim et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
- (2011) A. D. Shapiro et al. BLOOD
- Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
- (2011) Kamilla Swiech et al. BMC BIOTECHNOLOGY
- The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
- (2011) Xun Xu et al. NATURE BIOTECHNOLOGY
- Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
- (2010) Andreas Berting et al. BIOTECHNOLOGY AND BIOENGINEERING
- Prolonged activity of factor IX as a monomeric Fc fusion protein
- (2010) R. T. Peters et al. BLOOD
- Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
- (2010) Massimo Franchini et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
- (2010) Wolfgang Glaesner et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Erythropoietin Produced in a Human Cell Line (Dynepo) Has Significant Differences in Glycosylation Compared with Erythropoietins Produced in CHO Cell Lines
- (2010) Zahra Shahrokh et al. MOLECULAR PHARMACEUTICS
- Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins
- (2010) Carlos J Bosques et al. NATURE BIOTECHNOLOGY
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
- (2010) Darius Ghaderi et al. NATURE BIOTECHNOLOGY
- Expression systems for therapeutic glycoprotein production
- (2009) Yves Durocher et al. CURRENT OPINION IN BIOTECHNOLOGY
- Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety
- (2009) Michael Beck EXPERT OPINION ON BIOLOGICAL THERAPY
- An improved manufacturing process for Xyntha/ReFacto AF
- (2009) B. KELLEY et al. HAEMOPHILIA
- Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II
- (2008) J Edmond Wraith ACTA PAEDIATRICA
- Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)
- (2008) Esther Llop et al. ANALYTICAL BIOCHEMISTRY
- An overview of animal cell substrates for biological products
- (2008) John Petricciani et al. BIOLOGICALS
- Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells
- (2008) Martin Loignon et al. BMC BIOTECHNOLOGY
- Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
- (2008) Gudrun Schiedner et al. BMC BIOTECHNOLOGY
- Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
- (2008) V. Padler-Karavani et al. GLYCOBIOLOGY
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
- (2008) Christine H. Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
- (2008) A.B.H. Bakker et al. VACCINE
- Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity
- (2007) M.J.E. Havenga et al. BIOTECHNOLOGY AND BIOENGINEERING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now